Skip to content


Volume 17 Supplement 4

Sepsis 2013

  • Poster presentation
  • Open Access

Role of inflammatory caspases in a murine two-hit model of sepsis: analysis of immunosuppression and cognitive impairment

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 2,
  • 1 and
  • 1, 2
Critical Care201317 (Suppl 4) :P105

  • Published:


  • Cognitive Impairment
  • Hypoglycemia
  • Pseudomonas Aeruginosa
  • Severe Sepsis
  • Sham Group


Morbidities associated with severe sepsis are serious problems for surviving patients, such as cognitive impairment and immunosuppression. The immunosuppression predisposes the patients to a second infection, which generally is fatal. Several studies have been made to understand the mediators involved with this immunosuppression associated with sepsis. Some data from the literature show that caspase-1 promotes activation of cytokines, such as IL-1β, and actions are inhibited by caspase-12. This study proposes to analyze the role of inflammatory caspases in immunosuppression and cognitive damage associated with a two-hit model of sepsis.

Materials and methods

We submitted Swiss animals to the model of two hits of infection. The first hit was the CLP model and the second hit was intratracheal instillation of Pseudomonas aeruginosa. We analyze the mortality rate and the inflammatory profile of the animals submitted to the CLP model and the two-hit sepsis model. The cognition of the animals was tested by the passive avoidance test 15 and 21 days after the CLP and 21 days until 96 days after the two-hit sepsis model.


First we characterize the model and we observed a 30% survival rate of the CLP group in comparison with a 100% survival rate in the SHAM group. The high mortality of the CLP group was associated with hypoglycemia in the first 72 hours after the infection, increased neutrophil accumulation in the peritoneal cavity 6 and 24 hours after the CLP and an increase of inflammatory cytokines 6 hours after the CLP, such as CCL2, IL-1β and IL-10. The CLP group had a cognitive impairment 15 days after the CLP, but the memory was recovered 21 days after the infection. The CLP group was more susceptible to P. aeruginosa infection 21 days after the CLP, when we compare with the SHAM group. The CLP + P. aeruginosa group had a low count of neutrophils in BAL when compared with the SHAM + P. aeruginosa group. We observed a decrease in caspase-1 expression and an increased expression of caspase-12 in the lungs of the CLP + P. aeruginosa group. When we look to cognition, both the SHAM + P. aeruginosa and CLP + P. aeruginosa groups had cognitive impairment 21 days after the infection, and the cognitive impairment remained until 96 days in the SHAM + P. aeruginosa group after the infection, but the CLP + P. aeruginosa recovered the memory 96 days after the infection.


Our preliminary results suggest that the immunosuppression associated with the CLP model (first hit) led to more susceptibility for survivor animals, which succumbed to a pneumonia model (second hit). We observed the involvement of inflammatory caspases in this immunosuppression phenomenon with a decrease of caspase-1 and an increase in caspase-12 expression. When we observed the cognitive function, we observed that the animals submitted to CLP had a cognitive impairment 15 days after the infection and the infection with P. aeruginosa induced a cognitive impairment until 96 days in both in groups. However, further studies should be made to confirm these results.

Authors’ Affiliations

Laboratório de Imunofarmacologia, RJ, Brazil
Instituto de Pesquisa Evandro Chagas (IPEC), RJ, Brazil


© da Cunha et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.